Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06388590 · ClinicalTrials.gov registry record · NA
Acupuncture for Chronic Pelvic Pain
A NA study of Pelvic Pain and Acupuncture, sponsored by David Moss.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT06388590: Recruiting NA study of Pelvic Pain and Acupuncture, sponsored by David Moss.
NCT06388590 is a NA study of Pelvic Pain and Acupuncture that is actively recruiting participants, run by David Moss. The registered enrollment target is 64 participants, below the 369-participant average among 23 other Pelvic Pain trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06388590, a NA study of Pelvic Pain and Acupuncture, is actively recruiting participants, sponsored by David Moss.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to determine if alternative pain management strategies, namely acupuncture, may help reduce intensity of female pelvic pain compared to other pain control modalities. This research study will focus specifically on the Dragon's protocol of acupuncture which will seek to alleviate chronic non-endometriosis pelvic pain for women both with and without a history of sexual assault. This study may support evidence for an inexpensive alternative means of treatment for patients with or without traumatic sexual history and chronic pelvic pain.
Primary Outcome
The DVPRS consists of an 11-point numerical rating scale with 0 indicating no pain and 10 indicating severe pain. It has been confirmed for reliability and validity in measuring both acute and chronic pain and is currently the standard for pain measurement throughout DoD and VA health systems. The DVPRS has demonstrated linear scale qualities allowing parametric methods to be used.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER Dragons
Study Locations (1)
Nevada
- Mike O'Callaghan Military Medical Center - Nellis Air Force Base
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT06388590 shows while recruiting
NCT06388590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 369-participant average among 23 other Pelvic Pain trials with a reported enrollment target (83% lower).
The record links to 3 conditions, with Pelvic Pain appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT06388590 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT06388590 about?
NCT06388590 is a clinical study titled "Acupuncture for Chronic Pelvic Pain". The objective of this study is to determine if alternative pain management strategies, namely acupuncture, may help reduce intensity of female pelvic pain compared to other pain control modalities. This research study will focus specifically on the Dragon's protocol of acupuncture which will seek to...
What is the current status of trial NCT06388590?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2024-12-01. Estimated completion is 2026-04.
What conditions does trial NCT06388590 study?
This clinical trial studies the following conditions: Pelvic Pain, Acupuncture, Gynecology.
What interventions are being tested in trial NCT06388590?
The interventions under investigation include: Standard of Care (OTHER), Dragons (OTHER).
Who is sponsoring clinical trial NCT06388590?
This trial is sponsored by David Moss, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06388590 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06388590's enrollment target sits among peer trials
64 13th of 23 higher than 11 of 23 other Pelvic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
RECRUITING · NA
-
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
RECRUITING · NA
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
-
VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia
RECRUITING · NA
-
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
RECRUITING · NA
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI